nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—SIGMAR1—Progesterone—uterine cancer	0.735	1	CbGbCtD
Phentolamine—NISCH—Podofilox—Etoposide—uterine cancer	0.00681	0.681	CbGdCrCtD
Phentolamine—Tenderness—Progesterone—uterine cancer	0.00486	0.0321	CcSEcCtD
Phentolamine—NISCH—uterine cervix—uterine cancer	0.00481	0.0462	CbGeAlD
Phentolamine—Injection site pain—Medroxyprogesterone Acetate—uterine cancer	0.00471	0.0311	CcSEcCtD
Phentolamine—NISCH—smooth muscle tissue—uterine cancer	0.00467	0.0449	CbGeAlD
Phentolamine—Oral pain—Epirubicin—uterine cancer	0.00466	0.0308	CcSEcCtD
Phentolamine—NISCH—decidua—uterine cancer	0.00458	0.0441	CbGeAlD
Phentolamine—Tenderness—Medroxyprogesterone Acetate—uterine cancer	0.0044	0.0291	CcSEcCtD
Phentolamine—Oral pain—Doxorubicin—uterine cancer	0.00431	0.0285	CcSEcCtD
Phentolamine—Blood pressure increased—Progesterone—uterine cancer	0.00424	0.028	CcSEcCtD
Phentolamine—NISCH—mammalian vulva—uterine cancer	0.00421	0.0405	CbGeAlD
Phentolamine—ADRA1D—epithelium—uterine cancer	0.00405	0.0389	CbGeAlD
Phentolamine—NISCH—uterus—uterine cancer	0.00401	0.0385	CbGeAlD
Phentolamine—Blood pressure increased—Medroxyprogesterone Acetate—uterine cancer	0.00384	0.0254	CcSEcCtD
Phentolamine—ADRA1B—renal system—uterine cancer	0.00384	0.0369	CbGeAlD
Phentolamine—Injection site reaction—Medroxyprogesterone Acetate—uterine cancer	0.00382	0.0252	CcSEcCtD
Phentolamine—SIGMAR1—myometrium—uterine cancer	0.00359	0.0346	CbGeAlD
Phentolamine—Nasal congestion—Progesterone—uterine cancer	0.00338	0.0223	CcSEcCtD
Phentolamine—NISCH—female gonad—uterine cancer	0.00328	0.0315	CbGeAlD
Phentolamine—NISCH—vagina—uterine cancer	0.00326	0.0313	CbGeAlD
Phentolamine—SIGMAR1—Levonorgestrel—Progesterone—uterine cancer	0.0032	0.319	CbGdCrCtD
Phentolamine—ADRA1D—female reproductive system—uterine cancer	0.00301	0.0289	CbGeAlD
Phentolamine—ADRA2C—myometrium—uterine cancer	0.00282	0.0271	CbGeAlD
Phentolamine—SIGMAR1—uterine cervix—uterine cancer	0.0028	0.0269	CbGeAlD
Phentolamine—SIGMAR1—smooth muscle tissue—uterine cancer	0.00272	0.0261	CbGeAlD
Phentolamine—SIGMAR1—decidua—uterine cancer	0.00266	0.0256	CbGeAlD
Phentolamine—Angina pectoris—Progesterone—uterine cancer	0.00259	0.0171	CcSEcCtD
Phentolamine—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00255	0.0168	CcSEcCtD
Phentolamine—SIGMAR1—endometrium—uterine cancer	0.00253	0.0243	CbGeAlD
Phentolamine—Pain—Carboplatin—uterine cancer	0.00246	0.0163	CcSEcCtD
Phentolamine—SIGMAR1—mammalian vulva—uterine cancer	0.00245	0.0235	CbGeAlD
Phentolamine—SIGMAR1—uterus—uterine cancer	0.00233	0.0224	CbGeAlD
Phentolamine—ADRA1A—epithelium—uterine cancer	0.00232	0.0224	CbGeAlD
Phentolamine—ADRA2A—myometrium—uterine cancer	0.00225	0.0217	CbGeAlD
Phentolamine—ADRA2C—uterine cervix—uterine cancer	0.0022	0.0211	CbGeAlD
Phentolamine—ADRA1A—renal system—uterine cancer	0.00216	0.0207	CbGeAlD
Phentolamine—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.014	CcSEcCtD
Phentolamine—NISCH—lymph node—uterine cancer	0.00211	0.0203	CbGeAlD
Phentolamine—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.00211	0.0139	CcSEcCtD
Phentolamine—ADRA2C—decidua—uterine cancer	0.00209	0.0201	CbGeAlD
Phentolamine—ADRA2C—renal system—uterine cancer	0.00205	0.0198	CbGeAlD
Phentolamine—ADRA2C—endometrium—uterine cancer	0.00199	0.0191	CbGeAlD
Phentolamine—Cardiac disorder—Progesterone—uterine cancer	0.00198	0.013	CcSEcCtD
Phentolamine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00196	0.013	CcSEcCtD
Phentolamine—Angiopathy—Progesterone—uterine cancer	0.00193	0.0128	CcSEcCtD
Phentolamine—ADRA2C—mammalian vulva—uterine cancer	0.00192	0.0185	CbGeAlD
Phentolamine—Mediastinal disorder—Progesterone—uterine cancer	0.00192	0.0127	CcSEcCtD
Phentolamine—SIGMAR1—female gonad—uterine cancer	0.00191	0.0183	CbGeAlD
Phentolamine—SIGMAR1—vagina—uterine cancer	0.0019	0.0182	CbGeAlD
Phentolamine—ADRA2C—uterus—uterine cancer	0.00183	0.0176	CbGeAlD
Phentolamine—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.0118	CcSEcCtD
Phentolamine—ADRA2A—uterine cervix—uterine cancer	0.00175	0.0169	CbGeAlD
Phentolamine—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.0116	CcSEcCtD
Phentolamine—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.0115	CcSEcCtD
Phentolamine—ADRA2A—decidua—uterine cancer	0.00167	0.0161	CbGeAlD
Phentolamine—Hypertension—Progesterone—uterine cancer	0.0016	0.0106	CcSEcCtD
Phentolamine—ADRA2A—endometrium—uterine cancer	0.00159	0.0152	CbGeAlD
Phentolamine—Chest pain—Progesterone—uterine cancer	0.00158	0.0104	CcSEcCtD
Phentolamine—ADRA2A—mammalian vulva—uterine cancer	0.00153	0.0147	CbGeAlD
Phentolamine—ADRA2C—female gonad—uterine cancer	0.0015	0.0144	CbGeAlD
Phentolamine—Injection site pain—Epirubicin—uterine cancer	0.00149	0.00983	CcSEcCtD
Phentolamine—ADRA2C—vagina—uterine cancer	0.00149	0.0143	CbGeAlD
Phentolamine—Nervous system disorder—Progesterone—uterine cancer	0.00148	0.0098	CcSEcCtD
Phentolamine—Tachycardia—Progesterone—uterine cancer	0.00148	0.00975	CcSEcCtD
Phentolamine—ADRA2A—uterus—uterine cancer	0.00146	0.014	CbGeAlD
Phentolamine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00944	CcSEcCtD
Phentolamine—Hypotension—Progesterone—uterine cancer	0.00141	0.00933	CcSEcCtD
Phentolamine—Flushing—Dactinomycin—uterine cancer	0.0014	0.00922	CcSEcCtD
Phentolamine—Injection site pain—Doxorubicin—uterine cancer	0.00138	0.0091	CcSEcCtD
Phentolamine—Paraesthesia—Progesterone—uterine cancer	0.00136	0.00897	CcSEcCtD
Phentolamine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00888	CcSEcCtD
Phentolamine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00883	CcSEcCtD
Phentolamine—ADRA2A—female reproductive system—uterine cancer	0.00131	0.0126	CbGeAlD
Phentolamine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00131	0.00862	CcSEcCtD
Phentolamine—Pain—Progesterone—uterine cancer	0.00129	0.00854	CcSEcCtD
Phentolamine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00846	CcSEcCtD
Phentolamine—Gastrointestinal pain—Progesterone—uterine cancer	0.00124	0.00817	CcSEcCtD
Phentolamine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00813	CcSEcCtD
Phentolamine—SIGMAR1—lymph node—uterine cancer	0.00123	0.0118	CbGeAlD
Phentolamine—Injection site reaction—Epirubicin—uterine cancer	0.00121	0.00798	CcSEcCtD
Phentolamine—Acute coronary syndrome—Etoposide—uterine cancer	0.0012	0.0079	CcSEcCtD
Phentolamine—Abdominal pain—Progesterone—uterine cancer	0.0012	0.0079	CcSEcCtD
Phentolamine—ADRA2A—female gonad—uterine cancer	0.00119	0.0115	CbGeAlD
Phentolamine—Myocardial infarction—Etoposide—uterine cancer	0.00119	0.00785	CcSEcCtD
Phentolamine—ADRA2A—vagina—uterine cancer	0.00119	0.0114	CbGeAlD
Phentolamine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00781	CcSEcCtD
Phentolamine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.0074	CcSEcCtD
Phentolamine—Injection site reaction—Doxorubicin—uterine cancer	0.00112	0.00738	CcSEcCtD
Phentolamine—Asthenia—Progesterone—uterine cancer	0.00109	0.00717	CcSEcCtD
Phentolamine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00716	CcSEcCtD
Phentolamine—Pruritus—Progesterone—uterine cancer	0.00107	0.00707	CcSEcCtD
Phentolamine—Diarrhoea—Progesterone—uterine cancer	0.00104	0.00683	CcSEcCtD
Phentolamine—Cardiac disorder—Etoposide—uterine cancer	0.00101	0.00668	CcSEcCtD
Phentolamine—Flushing—Etoposide—uterine cancer	0.00101	0.00668	CcSEcCtD
Phentolamine—Dizziness—Progesterone—uterine cancer	0.001	0.00661	CcSEcCtD
Phentolamine—Angiopathy—Etoposide—uterine cancer	0.000988	0.00653	CcSEcCtD
Phentolamine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000984	0.00649	CcSEcCtD
Phentolamine—Mediastinal disorder—Etoposide—uterine cancer	0.000982	0.00648	CcSEcCtD
Phentolamine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00097	0.0064	CcSEcCtD
Phentolamine—ADRA2C—lymph node—uterine cancer	0.000963	0.00926	CbGeAlD
Phentolamine—Vomiting—Progesterone—uterine cancer	0.000962	0.00635	CcSEcCtD
Phentolamine—Headache—Progesterone—uterine cancer	0.000948	0.00626	CcSEcCtD
Phentolamine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000938	0.00619	CcSEcCtD
Phentolamine—Pain—Dactinomycin—uterine cancer	0.000915	0.00604	CcSEcCtD
Phentolamine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000907	0.00599	CcSEcCtD
Phentolamine—Nausea—Progesterone—uterine cancer	0.000899	0.00593	CcSEcCtD
Phentolamine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000875	0.00577	CcSEcCtD
Phentolamine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000872	0.00576	CcSEcCtD
Phentolamine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000859	0.00567	CcSEcCtD
Phentolamine—Abdominal pain—Dactinomycin—uterine cancer	0.000845	0.00558	CcSEcCtD
Phentolamine—Hypertension—Etoposide—uterine cancer	0.000819	0.00541	CcSEcCtD
Phentolamine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000814	0.00538	CcSEcCtD
Phentolamine—Chest pain—Etoposide—uterine cancer	0.000807	0.00533	CcSEcCtD
Phentolamine—Orthostatic hypotension—Epirubicin—uterine cancer	0.000806	0.00532	CcSEcCtD
Phentolamine—Abdominal pain upper—Epirubicin—uterine cancer	0.000806	0.00532	CcSEcCtD
Phentolamine—ADRA2A—lymph node—uterine cancer	0.000768	0.00739	CbGeAlD
Phentolamine—Asthenia—Dactinomycin—uterine cancer	0.000767	0.00507	CcSEcCtD
Phentolamine—Tachycardia—Etoposide—uterine cancer	0.000755	0.00499	CcSEcCtD
Phentolamine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000746	0.00493	CcSEcCtD
Phentolamine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000746	0.00493	CcSEcCtD
Phentolamine—Angina pectoris—Epirubicin—uterine cancer	0.000743	0.00491	CcSEcCtD
Phentolamine—Diarrhoea—Dactinomycin—uterine cancer	0.000732	0.00483	CcSEcCtD
Phentolamine—Hypotension—Etoposide—uterine cancer	0.000723	0.00477	CcSEcCtD
Phentolamine—Paraesthesia—Etoposide—uterine cancer	0.000695	0.00459	CcSEcCtD
Phentolamine—Angina pectoris—Doxorubicin—uterine cancer	0.000688	0.00454	CcSEcCtD
Phentolamine—Vomiting—Dactinomycin—uterine cancer	0.00068	0.00449	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000668	0.00441	CcSEcCtD
Phentolamine—Pain—Etoposide—uterine cancer	0.000662	0.00437	CcSEcCtD
Phentolamine—Nausea—Dactinomycin—uterine cancer	0.000635	0.00419	CcSEcCtD
Phentolamine—Gastrointestinal pain—Etoposide—uterine cancer	0.000633	0.00418	CcSEcCtD
Phentolamine—Bradycardia—Epirubicin—uterine cancer	0.000622	0.0041	CcSEcCtD
Phentolamine—Abdominal pain—Etoposide—uterine cancer	0.000612	0.00404	CcSEcCtD
Phentolamine—Bradycardia—Doxorubicin—uterine cancer	0.000575	0.0038	CcSEcCtD
Phentolamine—Cardiac disorder—Epirubicin—uterine cancer	0.000567	0.00374	CcSEcCtD
Phentolamine—Flushing—Epirubicin—uterine cancer	0.000567	0.00374	CcSEcCtD
Phentolamine—Asthenia—Etoposide—uterine cancer	0.000555	0.00367	CcSEcCtD
Phentolamine—Angiopathy—Epirubicin—uterine cancer	0.000554	0.00366	CcSEcCtD
Phentolamine—Mediastinal disorder—Epirubicin—uterine cancer	0.00055	0.00363	CcSEcCtD
Phentolamine—Pruritus—Etoposide—uterine cancer	0.000548	0.00362	CcSEcCtD
Phentolamine—Arrhythmia—Epirubicin—uterine cancer	0.000546	0.0036	CcSEcCtD
Phentolamine—Diarrhoea—Etoposide—uterine cancer	0.00053	0.0035	CcSEcCtD
Phentolamine—Cardiac disorder—Doxorubicin—uterine cancer	0.000524	0.00346	CcSEcCtD
Phentolamine—Flushing—Doxorubicin—uterine cancer	0.000524	0.00346	CcSEcCtD
Phentolamine—Angiopathy—Doxorubicin—uterine cancer	0.000513	0.00338	CcSEcCtD
Phentolamine—Dizziness—Etoposide—uterine cancer	0.000512	0.00338	CcSEcCtD
Phentolamine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000509	0.00336	CcSEcCtD
Phentolamine—Arrhythmia—Doxorubicin—uterine cancer	0.000505	0.00333	CcSEcCtD
Phentolamine—Vomiting—Etoposide—uterine cancer	0.000492	0.00325	CcSEcCtD
Phentolamine—Headache—Etoposide—uterine cancer	0.000485	0.0032	CcSEcCtD
Phentolamine—Nausea—Etoposide—uterine cancer	0.00046	0.00304	CcSEcCtD
Phentolamine—Hypertension—Epirubicin—uterine cancer	0.000459	0.00303	CcSEcCtD
Phentolamine—Chest pain—Epirubicin—uterine cancer	0.000453	0.00299	CcSEcCtD
Phentolamine—Nervous system disorder—Epirubicin—uterine cancer	0.000426	0.00281	CcSEcCtD
Phentolamine—Hypertension—Doxorubicin—uterine cancer	0.000425	0.0028	CcSEcCtD
Phentolamine—Tachycardia—Epirubicin—uterine cancer	0.000423	0.0028	CcSEcCtD
Phentolamine—Chest pain—Doxorubicin—uterine cancer	0.000419	0.00276	CcSEcCtD
Phentolamine—Hypotension—Epirubicin—uterine cancer	0.000405	0.00268	CcSEcCtD
Phentolamine—Nervous system disorder—Doxorubicin—uterine cancer	0.000394	0.0026	CcSEcCtD
Phentolamine—Tachycardia—Doxorubicin—uterine cancer	0.000392	0.00259	CcSEcCtD
Phentolamine—Paraesthesia—Epirubicin—uterine cancer	0.00039	0.00257	CcSEcCtD
Phentolamine—Hypotension—Doxorubicin—uterine cancer	0.000375	0.00248	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000375	0.00247	CcSEcCtD
Phentolamine—Pain—Epirubicin—uterine cancer	0.000371	0.00245	CcSEcCtD
Phentolamine—Paraesthesia—Doxorubicin—uterine cancer	0.00036	0.00238	CcSEcCtD
Phentolamine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000355	0.00234	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000347	0.00229	CcSEcCtD
Phentolamine—Pain—Doxorubicin—uterine cancer	0.000343	0.00227	CcSEcCtD
Phentolamine—Abdominal pain—Epirubicin—uterine cancer	0.000343	0.00226	CcSEcCtD
Phentolamine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000328	0.00217	CcSEcCtD
Phentolamine—Abdominal pain—Doxorubicin—uterine cancer	0.000317	0.0021	CcSEcCtD
Phentolamine—Asthenia—Epirubicin—uterine cancer	0.000311	0.00206	CcSEcCtD
Phentolamine—Pruritus—Epirubicin—uterine cancer	0.000307	0.00203	CcSEcCtD
Phentolamine—Diarrhoea—Epirubicin—uterine cancer	0.000297	0.00196	CcSEcCtD
Phentolamine—Asthenia—Doxorubicin—uterine cancer	0.000288	0.0019	CcSEcCtD
Phentolamine—Dizziness—Epirubicin—uterine cancer	0.000287	0.00189	CcSEcCtD
Phentolamine—Pruritus—Doxorubicin—uterine cancer	0.000284	0.00188	CcSEcCtD
Phentolamine—Vomiting—Epirubicin—uterine cancer	0.000276	0.00182	CcSEcCtD
Phentolamine—Diarrhoea—Doxorubicin—uterine cancer	0.000275	0.00181	CcSEcCtD
Phentolamine—Headache—Epirubicin—uterine cancer	0.000272	0.00179	CcSEcCtD
Phentolamine—Dizziness—Doxorubicin—uterine cancer	0.000265	0.00175	CcSEcCtD
Phentolamine—Nausea—Epirubicin—uterine cancer	0.000258	0.0017	CcSEcCtD
Phentolamine—Vomiting—Doxorubicin—uterine cancer	0.000255	0.00169	CcSEcCtD
Phentolamine—Headache—Doxorubicin—uterine cancer	0.000252	0.00166	CcSEcCtD
Phentolamine—Nausea—Doxorubicin—uterine cancer	0.000238	0.00157	CcSEcCtD
